Journal
RSC MEDICINAL CHEMISTRY
Volume 13, Issue 12, Pages 1614-1620Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2md00239f
Keywords
-
Funding
- AstraZeneca
- Astex Pharmaceuticals
- Lilly
- Pfizer
- Vernalis
- EPSRC
- BBSRC [BB/N008332/1]
- University of York
- Asahi Kasei
- Royal Society [INF\R1\191028]
Ask authors/readers for more resources
This study reports the synthesis of piperidine-based 3D fragment building blocks and demonstrates their suitability for fragment-based drug discovery programs.
Fragment-based drug discovery is now widely adopted for lead generation in the pharmaceutical industry. However, fragment screening collections are often predominantly populated with flat, 2D molecules. Herein, we report the synthesis of piperidine-based 3D fragment building blocks - 20 regio- and diastereoisomers of methyl substituted pipecolinates using simple and general synthetic methods. cis-Piperidines, accessed through a pyridine hydrogenation were transformed into their trans-diastereoisomers using conformational control and unified reaction conditions. Additionally, diastereoselective lithiation/trapping was utilised to access trans-piperidines. Analysis of a virtual library of fragments derived from the 20 cis- and trans-disubstituted piperidines showed that it consisted of 3D molecules with suitable molecular properties to be used in fragment-based drug discovery programs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available